https://www.sciencedaily.com/releases/2020/09/200901085306.htm

In 2018 alone, Canadian patients faced shortages for hundreds of medications, including EpiPens, opioid drugs, and treatments for Parkinson's disease, schizophrenia, and depression.

In many cases, these shortages can have severe and life-threatening consequences. While there are several studies from the United States about this topic, there have been very few investigations about drug shortages in Canada, mostly due to lack of reliable data.